Skip to content

Lenvatinib

Brand name: Lenvima

Lenvatinib comes in 10 pill versions in our database, in 8 strengths, from 2 manufacturers. Check the imprint to tell them apart.

Lenvatinib pill images

4 mg 2 pills

8 mg 1 pill

10 mg 2 pills

12 mg 1 pill

14 mg 1 pill

18 mg 1 pill

20 mg 1 pill

24 mg 1 pill

What is Lenvatinib used for?

Lenvatinib is used for renal cell carcinoma and thyroid neoplasms.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Differentiated Thyroid Cancer

LENVIMA is indicated for the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).

Renal Cell Carcinoma

LENVIMA, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).

LENVIMA, in combination with everolimus, is indicated for the treatment of adult patients with advanced RCC following one prior anti-angiogenic therapy.

Hepatocellular Carcinoma

LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).

Endometrial Carcinoma

LENVIMA, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma (EC) that is mismatch repair proficient (pMMR) or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.

From the FDA-approved label on DailyMed (published Jun 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.